Seaport Therapeutics, Inc. (SPTX)
NASDAQ · Manufacturing · Pharmaceutical preparations
$21.52+$0.4000 (+1.89%) on the dayAs of the close; data may be delayed.
SPTX price, last 12 months
Key stats
- Previous close
- $21.12
- Open
- $21.60
- Day range
- $21.45 – $22.44
- 52-week range
- $14.85 – $28.38
- Volume
- 96.5K
- Avg volume (20 days)
- 259.3K
- Market cap
- $1.2B
Performance
1W+0.6%
1M−22.7%
3M+0.6%
6M—
YTD—
1Y—
Technicals and fundamentals
About Seaport Therapeutics, Inc.
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.2B